MLchartDataset catalogue

DC-OVA vaccine

Term · Oncology and biomedicine · MLC-T-ONC-012939

An autologous, multivalent dendritic cell vaccine targeting ovarian cancer with potential immunostimulating and antineoplastic activities. DC-OVA vaccine is produced in vitro by pulsing autologous dendritic cells with killed autologous primary ovarian tumors as a source of tumor-associated antigens (TAAs); the pulsed DCs are then matured using various cytokines. Upon administration, DC-OVA vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against ovarian cancer TAA-expressing ovarian cancer cells.

Table 1. Record
IdentifierMLC-T-ONC-012939
FieldOncology and biomedicine
AbbreviationDC-OVA
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012939",
  "term": "DC-OVA vaccine",
  "field": "Oncology and biomedicine",
  "definition": "An autologous, multivalent dendritic cell vaccine targeting ovarian cancer with potential immunostimulating and antineoplastic activities. DC-OVA vaccine is produced in vitro by pulsing autologous dendritic cells with killed autologous primary ovarian tumors as a source of tumor-associated antigens (TAAs); the pulsed DCs are then matured using various cytokines. Upon administration, DC-OVA vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against ovarian cancer TAA-expressing ovarian cancer cells.",
  "abbreviation": "DC-OVA",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dc-ova-vaccine/"
}

Record 5,733 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.